Christopher Bunka - Sep 1, 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Signature
/Chris Bunka/
Stock symbol
LEXX
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/2/2021, 01:58 PM
Previous filing
Jun 9, 2021
Next filing
Aug 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 216K Sep 1, 2021 Private Holding Company
holding LEXX common shares 274K Sep 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +15K +26.79% $0.00 71K Sep 1, 2021 Common Shares 15K $6.23 Direct
holding LEXX Warrants 6.67K Sep 1, 2021 Common Shares 6.67K $10.50 Private Holding Company
holding LEXX Stock Options 32.7K Sep 1, 2021 Common Shares 26K $5.83 Direct
holding LEXX Stock Options 56K Sep 1, 2021 Common Shares 23.3K $7.08 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.